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Abstract: T cells develop in the thymus, which provides an essential environment for T cell fate
specification, and for the differentiation of multipotent progenitor cells into major histocompatibility
complex (MHC)-restricted, non-autoreactive T cells. Here we review the role of the Hedgehog
signalling pathway in T cell development, thymic epithelial cell (TEC) development, and
thymocyte–TEC cross-talk in the embryonic mouse thymus during the last week of gestation.
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1. Introduction
T cells develop in the thymus, which provides an essential environment for T cell fate specification,
and for the differentiation of multipotent progenitor cells into major histocompatibility complex
(MHC)-restricted, non-autoreactive T cells. Here we review the role of the hedgehog (Hh) signalling
pathway in T cell development, thymic epithelial cell (TEC) development, and thymocyte–TEC
cross-talk in the embryonic thymus.
The thymus is an epithelial organ surrounded by a mesenchymal capsule. In the mouse
embryo, it develops from the third pharyngeal pouches, which also gives rise to the parathyroids [1].
By embryonic day (E)12.5, the thymus and parathyroid have become distinct organs, and the thymus
first starts to be seeded by haematopoietic progenitor cells that migrate from the foetal liver. Progenitor
cells enter the thymus from the outside through the capsule, and migrate towards the center of the
thymus as they differentiate (illustrated in Figure 1). This is in contrast to the adult thymus, which is
seeded by progenitors that enter through blood vessels at the corticomedullary junction.
During embryonic life, mature T cells are first produced on ~E18.5, which then start to leave the
thymus and move to peripheral lymphoid organs by birth. In addition, TECs develop into two distinct
populations—medullary(m) TEC and cortical(c) TEC—with different functions and locations within
the thymus [2]. Haematopoietic progenitor cells are dependent on cTEC for T cell fate specification
and positive selection of the T cell receptor repertoire (TCR), while mTEC are necessary for tolerance
induction (negative selection of the TCR repertoire and differentiation of regulatory T cells) [3]. At the
same time, TECs require signals from thymocytes for their development, and thymocyte–TEC cross
talk in the embryonic thymus has been shown to be essential for establishment of the mature mTEC
population and the architecture of the mature thymus, while its role in cTEC differentiation is less
well-defined [2,4,5].
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Figure 1. Hedgehog (Hh) expression in different microenvironments as thymocytes migrate through 
the embryonic thymus. The cartoon illustrates the stages of T cell development in the embryonic 
thymus, as developing thymocytes move through different thymus microenvironments and receive 
different amounts of Hh signal. Molecules of Indian hedgehog (Ihh, expressed by double positive 
(DP) thymocytes) are shown in green, and molecules of Sonic hedgehog (Shh, expressed by TEC in 
the sucbcapsular region and medulla) are shown in yellow. Progenitor cells first enter the embryonic 
thymus through the capsule on ~E12.5, and migrate towards the centre of the thymus as they 
differentiate. DP cells first appear on E16.5 and are located in the cortex. Mature single positive (SP) T 
cells and mature medullary TEC (mTEC) and cortical TEC (cTEC) populations are present by birth.  
During T cell development, thymocytes pass through a series of stages that have been defined 
by the expression of cell surface markers as they migrate through the thymus [6] (see Figure 1). In 
brief, the earliest thymocytes—termed CD4−CD8− double negative (DN)—rearrange the TCRβ chain 
locus and express the pre-TCR in order to differentiate to the CD4+CD8+ double positive (DP) stage. 
They then rearrange the TCRα locus and must signal through the αβTCR to differentiate to mature 
CD4+ single positive (SP) or CD8+ SP T cell. The DN population has been further subdivided by cell 
surface expression of CD44 and CD25. The earliest DN1 populations are CD44+CD25−; these then 
acquire CD25 expression (DN2), lose CD44 expression (DN3), and finally become CD44−CD25− 
(DN4) cells before differentiating to DP cell, often via a CD8+ immature single positive (ISP) 
intermediate.  
The development of TEC in the embryonic thymus is less well understood, but both lineages of 
TEC originate from a common CD45−Epcam-1+CD40lowCD205low progenitor cell population [7,8]. As 
development proceeds, these cells gain greater intensity of CD40 and CD205 expression, resulting in 
transitional progenitors which have the potential to differentiate into two populations—cTEC 
(CD40intCD205highLy51+) or mTEC (CD40highCD205lowUEA-1+) [9,10].  
2. Expression of Hedgehog (Hh) Proteins and Pathway Components in the Embryonic Thymus 
There are three mammalian Hh proteins (Sonic Hh, Shh; Indian Hh, Ihh; and Desert Hh, Dhh), 
which share a common signalling pathway [11]. When Hh proteins bind to their cell surface receptor 
Patched1 (Ptch1), the inhibition of Ptch1 on the signal transducer molecule Smoothened (Smo) is 
Figure 1. Hedgehog (Hh) expression in different microenvironments as thymocytes migrate through
the embryonic thymus. The cartoon illustrates the stages of T cell development in the embryonic
thymus, as developing thymocytes move throu ifferen thymus microenvironments and receive
different amounts of Hh signal. Molecules of I i hedgehog (Ihh, expresse by double positive
(DP) thymocytes) are shown in green, and molecules of Sonic hedgehog (Shh, expressed by TEC in
the sucbcapsular region and medulla) are shown in yellow. Progenitor cells first enter the embryonic
thymus through the capsule on ~E12.5, and migrate towards the centre of the thymus as they
differentiate. DP cells first appear on E16.5 and are located in the cortex. Mature single positive
(SP) T cells and mature medullary TEC (mTEC) and cortical TEC (cTEC) populations are present
by birth.
During T cell development, thymocytes pass through a series of stages that have been defined by
the expression of cell surface markers as they migrate through the thymus [6] (see Figure 1). In brief,
the earliest thymocytes—termed CD4´CD8´ double negative (DN)—rearrange the TCRβ chain locus
and express the re-TCR in order to differentiate to the CD4+CD8+ double positive (DP) stage. They
then rearrange the TCRα locus and must signal through the αβTCR to differentiate to mature CD4+
single positive (SP) or CD8+ SP T cell. The DN population has been further subdivided by cell surface
expression of CD44 and CD25. The earliest DN1 populations are CD44+CD25´; these then acquire
CD25 expressio (DN2), lose CD44 expression (DN3), and finally b come CD44´CD25´ (DN4) cells
before differentiating to DP cell, often via a CD8+ immature single positive (ISP) i termediate.
The development of TEC in the embryonic thymus is less well understood, but both lineages of
TEC originate from a common CD45´Epcam-1+CD40lowCD205low progenitor cell population [7,8].
As development proceeds, these cells gain greater intensity of CD40 and CD205 expression, resulting
in transitional progenitors which have the potential to differentiate into two populations—cTEC
(CD40intCD205highLy51+) or mTEC (CD40highCD205lowUEA-1+) [9,10].
2. Expression of Hedgehog (Hh) Proteins and Pathway Components in the Embryonic Thymus
There are three mammalian Hh proteins (Sonic Hh, Shh; Indian Hh, Ihh; and Desert Hh, Dhh),
which share a common signalling pathway [11]. When Hh proteins bind to their cell surface
receptor Patched1 (Ptch1), the inhibition of Ptch1 on the signal transducer molecule Smoothened
(Smo) is relieved, and Smo transduces the Hh signal. At the end of the signalling pathway are the
Gli family of transcription factors (Gli1, Gli2 and Gli3). Gli1 is an activator of transcription only,
whereas Gli2 and Gli3 can be processed (cleavage and post-translational modification) to function as
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repressors of transcription in the absence of Hh and activators of transcription when the Hh signal is
transduced [12,13]. Gli2 functions predominantly as a transcriptional activator in vivo and is required
to initiate the Hh signal [14]. In general, Gli3 functions as a transcriptional repressor in vivo, and
can act to repress expression of Shh by repression of an intermediate transcriptional activator [15].
Hh proteins are required for patterning, organogenesis, and cell fate determination in many tissues
during development, including the foetal thymus [16–20].
Reverse transcription (RT)-PCR has shown that developing foetal thymocytes express the Gli
transcription factors, Ptch1, Smo, and Ihh, but not Shh; however, TEC express Shh [21–25]. Quantitative
(Q)RT-PCR from sorted thymocyte subsets on E16.5 showed that the Gli genes are differentially
expressed during T cell development, with highest expression of Gli2 in the DN1 and DN2 populations,
whereas Gli1 expression is highest in the DN3 population, and Gli3 in the DN4 population [21,23–25].
In contrast, Ihh expression is undetectable in the earliest DN thymocyte subsets, and is most highly
expressed in the DP population (Figures 1 and 2). Flow cytometry, RT-PCR and QRT-PCR have
demonstrated that Smo is highly expressed in DN thymocytes, and down-regulated following pre-TCR
signalling, whereas Ptch1 expression is maintained in DP cells [22]. Expression levels of Smo reduce
with maturity in the DP population, but DP cells can transduce Hh signals [26].
Hh pathway components are also expressed by TEC in the embryonic thymus [21,22,27–29].
We carried out microarray analysis of gene expression in fluorescence activated cell sorting
(Facs)-sorted cTEC and mTEC purified from E14.5 foetal thymus organ culture (FTOC) after 7 days in
culture to allow maturation of both cTEC and mTEC populations (GSE81433). This analysis showed
expression of Smo, Ptch1 and Hh genes, in addition to high expression of Gli3 (Figure 2B). Thus, in the
foetal thymus, TECs express both the Hh proteins and the machinery to transduce the Hh signal.
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Figure 2. Expression of components of the Hh signalling pathway in embryonic thymocytes and
TEC. (A) Graphs illustrate the relative expression of Gli1, Gli2, Gli3, and Ihh in sorted DN1, DN2,
DN3, DN4, and DP thymocytes from E16.5 thymus, determined by quantitative reverse transcription
polymerase chain reaction (QRT-PCR); (B) Plots show the normalised expression of Aire, Ptch1,
Smo, Shh, Ihh, Dhh, Gli1, Gli2, and Gli3 by microarray analysis (GSE81433) from fluorescence
activated cell sorting (Facs)-sorted cTEC (CD45´EpCam1+Ly51+UEA-1´, left-hand plot), and mTEC
(CD45´EpCam1+Ly51´UEA-1+, right-hand plot); populations prepared from E14.5 WT (C57BL/6)
foetal thymus organ culture (FTOC) after 7 days in culture. TEC were isolated as described [29].
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3. Regulation of T Cell Development by Hh Signalling
Analysis of T cell development in the foetal thymus of multiple Hh pathway mutants has shown
that Hh signalling is an important regulator of T cell development in the embryo, which affects several
stages of thymocyte development (Figure 3). We will review the experimental evidence showing that
Hh signalling influences three key check-points in embryonic αβT cell development: the transition
from DN1 to DN2 cell; pre-TCR induced differentiation to DP cell; and the transition from DP to
mature SP cell.
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Figure 3. Hh signalling regulates multiple stages of thymocyte development. The cartoon illustrates
the different stages of thymocyte differentiation that are regulated by Hh signalling in the embryonic
thymus. (TCR: T cell receptor.)
3.1. Hedgehog Signalling in DN1 and DN2 Cells
As developing thymocytes differentiate from the earliest DN1 progenitors to express cell surface
CD25 and become DN2 cells, they specify to the T cell fate, and initiate recombination of their TCRβ
gene locus [6]. At this stage, Shh, Gli2 and Gli3 are required for differentiation and expansion of the
DN2 population. Thymi from E13.5 Shh´/´ embryos are much smaller than those of wild type (WT)
littermates and have ~10 times fewer thymocytes and a reduction in the DN2 population [19]. Reduced
differentiation to DN2 cell has also been observed in E13.5 Gli2´/´ and Gli3´/´ thymus [23,25]. In
contrast, analysis of Gli1-deficient foetal thymus has shown that Gli1 is dispensable for the DN1 to DN2
transition [24]. In many tissues, Gli3 functions to repress Hh pathway activation, and Gli3-deficiency
has the opposite phenotype to Shh-deficiency, so the fact that mutants of both Shh and Gli3 show
reduced early thymocyte differentiation might seem surprising. However, the expression pattern of
the Gli transcription factors in the DN populations is consistent with the findings from the Gli-mutants
in early DN cell development. Gli2 and Gli3 are both highly expressed in DN1 and DN2 cells, while
expression of Gli1 in early DN subsets is relatively low (Figure 2).
The role of Ihh in early thymocyte development has also been studied [21]. Analysis of E13.5
Ihh´/´ thymus shows that deletion of Ihh alone has no influence on development at the DN1 to DN2
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transition. However, analysis of the double-mutant Shh+/´Ihh´/´ foetal thymus showed a reduction
in the DN2 population, indicating that Shh and Ihh have redundant functions at the DN1 to DN2
transition [21].
3.2. The Transition from DN to DP Cell and Pre-TCR Signalling
Differentiation from DN3 cell through to DP cell requires successful rearrangement of the TCRβ
gene locus and formation of the pre-TCR complex [6]. Signalling through the pre-TCR complex results
in a complex transcriptional programme, leading to expansion, survival, allelic exclusion of the TCRβ
gene locus, and differentiation to DP cell [30,31]. In foetal thymocyte development, differentiation
from DN3 to DN4 cell seems to be somewhat uncoupled from pre-TCR signal transduction and TCRβ
chain expression [32], and thymocytes that have failed to rearrange their TCRβ gene locus die at the
DN4 stage [32,33].
Hedgehog signalling to DN thymocytes negatively regulates pre-TCR-induced differentiation
to DP cell in both mouse and human [22,25,34]. The first evidence for this came from in vitro
studies which demonstrated that Hh signalling negatively regulates DN to DP differentiation in
foetal thymus organ cultures (FTOCs) that were treated with recombinant (r) Shh [22]. Thymocyte
development was arrested at the DN3 stage, whereas FTOCs treated with a neutralizing monoclonal
antibody (mAb) against Shh showed increased differentiation from DN to DP cell. Thymocytes from
Recombination-activating gene 1 (Rag1)´/´ FTOCs can be induced to differentiate from DN3 to DP
cell by treatment with anti-CD3 mAb, which mimics the pre-TCR signal [31,35]. Addition of the
anti-Shh mAb to anti-CD3 treated Rag1´/´ FTOC enhanced thymocyte differentiation to the DP
stage, whereas treatment with rShh arrested it, confirming the negative regulatory role of Shh at this
developmental stage.
In the embryo, DP cells first appear on E16.5, allowing observation of the transition from DN to
DP population in a synchronized manner. Analysis of the E16.5 Shh´/´ foetal thymus unexpectedly
showed that the transition from DN to DP cell was reduced compared to WT, in contrast to the in vitro
studies [19]. However, the E16.5 Shh´/´ thymus also had increased apoptosis in the DN4 population
compared to WT, consistent with increased death of cells that had failed to rearrange the TCRβ locus.
This suggested that the requirement for Shh before pre-TCR signalling might impact the production of
DP cells on E16.5 [19].
In vivo evidence for the negative regulatory role of Hh signalling at this developmental stage
came from analysis of foetal thymocyte development in embryos mutant for Gli2 and Gli3 [23,25]. From
E13.5 to E15.5 Gli2´/´ thymi were smaller than that of WT littermates, whereas the E17.5 Gli2´/´
thymus contained over twice as many thymocytes as WT. The expansion of the Gli2´/´ thymus on
the embryonic day after DP cells first appear, together with the expression pattern of Gli2 in the foetal
thymus which shows three-fold upregulation in DN4 compared to DN3 cells, suggested that Gli2
plays a negative role in thymocyte expansion and progression to DP after pre-TCR signal transduction
during foetal development. This was confirmed in anti-CD3-treated Rag1´/´Gli2´/´ FTOCs, which
expanded and differentiated to DP faster than their anti-CD3 treated Rag1´/´Gli2+/+ counterparts.
Interestingly, anti-CD3-treated Rag1´/´Shh´/´ FTOC also differentiated faster than anti-CD3-treated
Rag1´/´Shh+/+ FTOC, confirming that Gli2 is downstream of Shh as a negative regulator of
differentiation after pre-TCR signalling [25]. In contrast, analysis of anti-CD3-treated Rag1´/´
Gli3´/´ FTOCs revealed a partial arrest at the DN-to-DP stage after pre-TCR signalling [23]. The same
result was observed in E16.5 Gli3´/´ thymus, indicating that Gli3 functions as a transcriptional
repressor of the Hh pathway at this developmental stage, and that Gli3 activity is required for normal
differentiation from DN to DP cell.
Given that the Gli transcription factors are expressed by both stromal and thymocyte
compartments of the foetal thymus (Figure 2), these experiments with constitutive knockouts did
not test whether or not Shh was directly signalling to thymocytes to control their differentiation, or
whether the impact on T cell development was an indirect effect due to Hh signalling to TEC or
J. Dev. Biol. 2016, 4, 22 6 of 13
another stromal cell population. Therefore, the impact of Hh-mediated transcription in developing
thymocytes on their differentiation and function was investigated by the production of transgenic
(tg) mice which over-expressed activator (Gli2A-tg (Gli2∆N2-tg)), or repressor (Gli2R-tg (Gli2∆C2-tg))
forms of Gli2 in T lineage cells only (driven by the lck promoter) [36,37]. Anti-CD3-treated Rag1´/´
Gli2A-tg FTOC differentiated more slowly to DP than their non-transgenic counterparts, whereas
anti-CD3-treated Rag1´/´Gli2R-tg FTOC—in which physiological Hh-mediated transcription is
repressed—differentiated more quickly [25]. Thus, Hh pathway activation in developing thymocytes
negatively regulates pre-TCR-mediated differentiation to DP cell.
3.3. Ihh at the Transition from DN to DP Cell and Its Role in Homeostasis and the Control of DP Cell Number
Ihh is produced by both the foetal thymus stroma and developing thymocytes with a six-fold
higher expression in the DP population compared to DN cells and stroma, which show similar Ihh
expression levels [21] (Figure 2). The DP population expresses low levels of the target gene Gli1,
suggesting that Ihh is not signalling to the DP population in an autocrine manner, but feeding back to
signal to the DN3 population, which express the highest levels of Gli1.
In the E16.5 Ihh´/´ embryo, both thymocyte numbers and the proportion of DP cells were
reduced, indicating that Ihh promotes T cell development. Interestingly, however, the E16.5 Ihh+/´
thymus contained 2.4 times more DP cells than WT, implying that Ihh also negatively regulates
thymocyte development. Ihh+/+ Rag1´/´ FTOCs contained more cells than their Ihh+/´ Rag1´/´
counterparts, but after anti-CD3 treatment for 5 days, the Ihh+/´ Rag1´/´ FTOCs differentiated faster
than the Ihh+/+ Rag1´/´ FTOC, confirming that Ihh promotes early DN thymocyte development
before the pre-TCR signal, but negatively regulates the pre-TCR-induced transition to the DP stage.
In the Ihh+/´ E16.5 thymus, the sorted CD25+ DN population contained significantly more cells
in cell cycle (S/G2+M) than its WT counterpart. Taken together, these data indicated that Ihh produced
by the DP population feeds back to negatively regulate the differentiation and expansion of the DN3
population after pre-TCR signal transduction. Thus, as the total amount of Ihh protein present in the
thymus largely depends on the size of the DP population, this negative feedback loop may be thought
of as a counting system to regulate thymocyte number and maintain thymocyte homeostasis [21].
3.4. Hh Signalling in TCR Repertoire Selection and the Transition from DP to SP Cell
Hh signalling also plays an important role during the maturation of DP to CD4SP and CD8SP cell
in the embryonic thymus. Maturation from DP to SP cell occurs following successful rearrangement
of the TCRα gene locus, and requires TCR signalling: positive selection ensures appropriate
MHC-restriction of SP cells, followed by negative selection of potentially self-reactive clones [3,6].
Many models have been proposed to describe how DP thymocytes commit to the CD4 and CD8
lineages, and to explain how positive selection ensures that selected CD4 and CD8 SP populations
express TCR appropriately restricted by MHCII and MHCI, respectively [38]. Strength and duration
of the TCR signal that a developing cell receives broadly determine its fate, with the strongest
signals leading to negative selection, usually at the SP stage in the medulla (of TCR recognizing
self-antigens)—intermediate signals leading to positive selection, and weaker signals or lack of TCR
signalling leading to cell death by neglect. For DP thymocytes undergoing positive selection, TCR
signal strength and duration again influence CD4 and CD8 fate decision, with those cells receiving
stronger TCR signals tending to be biased towards the CD4 fate, and weaker/more transient signals
tending to favour differentiation to CD8 SP. TCR signal strength and duration are dependent on the
avidity of the TCR for its ligand (and therefore on the TCR sequence), but may also be modulated
by other factors, such as coreceptor signalling, intracellular or extracellular influences on TCR signal
transduction, and integration of the transcriptional outcome of TCR signalling with the transcriptional
context of the cell.
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Analysis of embryonic thymus from Shh´/´, Gli1´/´, Gli2´/´, Gli2A-transgenic (tg) and
Gli2R-tg, and in vitro FTOC experiments have all shown that Shh negatively regulates the DP to SP
transition, most likely by lowering TCR signal strength (see Figure 4) [24,26,36].
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The Shh´/´ embryonic thymus is smaller than WT but has a higher SP:DP ratio, reflecting an
accelerated rate of differentiation from DP to SP [36]. Shh´/´ FTOCs had a greater proportion of
mature CD4SP cells and an increased CD4SP:CD8SP ratio than WT (Figure 4A). Likewise, Gli2´/´ and
Gli1´/´ FTOCs showed increased differentiation from DP to SP cells and increased CD4SP:CD8SP
ratio [24]. The increased differentiation towards the CD4SP lineage might reflect an increase in TCR
signal strength, and both positive and negative selection of transgenic TCR were increased in Shh´/´,
Gli2´/´, and Gli1´/´ FTOC compared to control [24,36]. Analysis of the Gli2A-tg and Gli2R-tg
embryonic thymus confirmed that physiological Hh-mediated transcription in thymocytes negatively
regulates the DP-to-SP transition and TCR repertoire selection [26].
Cell surface CD5 intensity is an indicator of TCR signal strength on thymocytes, with higher
CD5 expression reflecting a stronger TCR signal and vice versa [39,40]. Gli2R-tg FTOCs, in which
physiological Hh-mediated transcription is inhibited, showed increased differentiation to CD4SP,
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higher CD5 expression on the CD4SP population, and a higher CD4SP:CD8SP ratio than WT [26].
Doubling the Gli2R-transgene copy number further increased the proportion of CD4SP cells, their
CD5 cell surface expression, and the CD4SP:CD8SP ratio [26]. Interestingly, these dose-dependent
phenotypic changes were reversed with rShh treatment of WT FTOC. Decreased cell surface CD5
expression and a lower CD4SP:CD8SP ratio were observed when WT FTOC were treated with rShh [36].
Therefore, an increased level of Shh signalling appeared to give rise to weaker TCR signal strength,
leading to reduced selection from DP to CD4SP; whereas selection to the CD8 lineage, which is believed
to require lower strength and duration of TCR signal transduction, was less affected.
Gata3 is a key regulator of CD4 lineage commitment, and strong TCR signals increase expression
of Gata3, which drives differentiation towards the CD4 lineage [41]. Interestingly, treatment of WT
FTOCs with rShh decreased the proportion of Gata3-expressing DP and SP cells, while attenuating
Shh signalling by treatment with the neutralising anti-Shh mAb increased the intensity and expression
of Gata3 on the DP and SP4 populations [26]. Thus, the influence of modulation of Shh signalling on
Gata3 expression is consistent with the effect of Shh on CD4/CD8 lineage commitment, and with its
influence on TCR signal strength [36,42].
TCR signal strength is a crucial determinant of the TCR repertoire and CD4/8 lineage commitment
and the influence of Shh on TCR signal strength may thus alter both of these: Since Shh-expressing
TECs are scattered around the medulla and the cortico-medullary junction, their influence on TCR
signal strength and the outcome of TCR ligation (i.e., positive or negative selection and CD4/8 lineage
decision) for each cell is dependent on the location of the cell relative to the source of Shh. It is therefore
possible that Shh-expressing TEC may have specialised functions in the thymus, such as induction of
positive selection or commitment to the CD8 lineage.
3.5. Gli3 Regulates Nos2 Expression during Negative Selection
Analysis of the Gli3 mutant thymus showed that Gli3 acts as a repressor of Hh signalling in the
foetal thymus and that Gli3 mutation may also influence TCR repertoire selection in developing
thymocytes [23,27]. These experiments were carried out using constitutive Gli3 knock-outs, so
that the lineage-specific requirements for Gli3 are not known, and both the Gli3´/´ foetal thymus
stroma and foetal thymocytes had increased expression of the transcriptional target of Hh-signalling,
Gli1 [24,27]. Treatment of Gli3´/´FTOC with a neutralising anti-Shh mAb reduced Gli1 expression
in the stroma [27], demonstrating that the increase in Gli1 expression was a result of increased
Hh signalling.
PCR array analysis of gene expression in the Gli3´/´ foetal thymus stroma compared to WT
identified Gli3-target genes in the stroma, and revealed that Nos2 is a Gli3 target gene, which was
significantly down regulated in the Gli3´/´ and Gli3+/´ stroma [27]. Nos2 expression recovered to
WT levels when Gli3+/´ FTOC was treated with an anti-Hh neutralising mAb, but was not affected
when Gli3´/´ FTOC were treated with an anti-Hh mAb, suggesting that Nos2 required Gli3 for
its physiological levels of expression (most likely through Gli3R’s repression of an intermediate
transcriptional repressor of Nos2) [27].
Nos2 is induced in the thymic stroma during negative selection. It causes the production of nitric
oxide (NO), a potent pro-apoptotic agent, which promotes apoptosis of autoreactive thymocytes [43].
Treatment of WT and Gli3´/´ FTOC with anti-CD3 mAb to mimic negative selection, showed that the
Gli3´/´DP cells had decreased intracellular active caspase-3 expression, correlating with a lower level
of apoptosis compared to WT. This suggests that negative selection-related apoptosis of DP thymocytes
is attenuated in the Gli3´/´ thymus and that this may be due to reduced Nos2 expression in the thymic
stroma. (Figure 4B). It is likely that this would lead to a change in the TCR repertoire and survival of
autoreactive thymocytes in the embryonic thymus. Indeed, negative selection of an MHCI-restricted
transgenic TCR is reduced in the adult Gli3+/´ thymus [27], although the impact of Gli3-mutation on
negative selection of a transgenic TCR has not been investigated in the embryonic thymus.
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4. Hedgehog Signalling in Foetal Thymic Epithelial Cell (TEC) Development and Function
The role of the Hh pathway in embryonic TEC development has been less extensively investigated
than its function in T cell development, although Shh is involved early in thymus organogenesis
during patterning of the pharyngeal pouches [44]. In this section, we will briefly discuss the early
role of Shh in pharyngeal patterning and thymus organogenesis before reviewing recent experiments
demonstrating that Hh signalling is required for normal TEC development in the embryonic thymus
during the last week of gestation.
Shh is involved in the formation and patterning of the entire pharyngeal apparatus and affects the
third pouch and the thymic anlage [44]. In Shh´/´ embryos, the development of the third pharyngeal
pouch is defective and the thymic rudiment fails to bud off entirely from the pharyngeal endoderm [45].
However, once the Shh´/´ thymus is formed, although it is small, it is capable of supporting T cell
development; however, there are defects in normal TEC development [19,21].
There are two types of TEC, which are derived from a common progenitor, and which have distinct
functions, localisations within the thymus, and cell surface markers [2,4,5,46]. Cortical(c) TECs provide
DL4 for T cell fate specification, and present MHC+peptide ligands for positive selection. These cTECs
are defined as EpCam1+, CD205+, Ly51+ and MHCII+, and express genes for antigen presentation,
including Cathepsin-L, Prss16, and β5t. Medullary(m) TECs are specialised for induction of negative
selection, are defined as cell surface EpCam1+, CD40+, CD205´, Ly51´ and MHCII+, and bind the
lectin UEA-1. They express the Aire gene and Cathepsin-S, facilitating the expression and presentation of
Tissue Restricted Antigens (TRA) for induction of tolerance. During embryonic development, the cell
surface markers CD40 and CD205 can be used to map TEC development. CD40lowCD205low progenitor
cells gain cell surface CD40 and CD205 expression, resulting in transitional progenitors which have
the potential to differentiate into the two mature populations: cTEC (CD40intCD205highLy51+) and
mTEC (CD40highCD205lowUEA-1+) [9,10].
Embryonic TECs express components of the Hh signalling pathway as well as the genes
encoding the Hh ligands (Figure 2). Therefore, to investigate if TECs are transducing Hh signals
in vivo in the embryonic thymus, Gli Binding Site (GBS)-Green Fluorescent Protein (GFP) transgenic
embryos—which report Hh-mediated transcription by expression of GFP—were analysed [27]. Hh
pathway activation was observed in the TEC populations of embryos from E14.5 through to birth
(neonate). The greatest intensity of GFP-fluorescence was observed on E14.5, and fluorescence was seen
in the CD40lowCD205low progenitor cells, which made up about one third of TEC, and in the emerging
CD40intCD205high and CD40highCD205low populations. On E18.5, higher expression was observed in
cells that had specified to the mTEC lineage. At birth, the CD40lowCD205low progenitor population
made up less than 1% of all TEC, but both the mature cTEC and mTEC populations contained about
20% of cells that expressed GFP [29].
Analysis of the Shh´/´ foetal thymus has recently shown that Shh is required for normal
TEC development and the regulation of mTEC/cTEC lineage choice [29]. In the Shh´/´ foetal
thymus, there was a reduction in thymus size, overall cell number, and number of thymocytes and
of TECs (CD45´EpCam1+) compared to WT littermates [19,21,29]. The numbers of both mature
cTECs (CD45´EpCam1+Ly51+UEA1´) and mTECs (CD45´EpCam1+Ly51´UEA1+) were reduced in
Shh´/´ compared to WT, but the mTEC lineage was particularly affected. The proportion of mTECs
generated in Shh´/´ FTOC fell from 27.4% to 13.2%, compared to WT FTOC, with a concomitant
increase in the proportion of mature cTECs [29]. Interestingly, although the number of TECs was
reduced in the Shh´/´ FTOC, cell surface expression of MHCII was increased in both cTEC and mTEC
(Figure 5) [29]. Expression of MHCII is essential on cTECs to provide ligands for positive selection
for differentiation from DP to CD4SP, and on mTECs for negative selection of MHCII-restricted
thymocytes. The increase in MHCII expression on cTECs and mTECs in the Shh´/´ foetal thymus
could therefore potentially influence the outcome of positive and negative selection of thymocytes
(Figures 3–5) [29]. Although there are overall fewer TECs in the Shh-deficient thymus, on each
individual TEC, more MHCII-plus-peptide complexes for positive and negative selection will be
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available to developing thymocytes, and so it is possible that this may affect the outcome of TCR
repertoire selection to the CD4 T cell lineage by changing MHCII-restricted TCR antigen dwell time or
avidity [47] (see Figures 4 and 5).
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Figure 5. Impact of Shh-deficiency and Gli3-deficiency on TEC differentiation and function. In the
Shh´/´ embryonic thymus, Hh protein levels are low, there are fewer TEC, and the ratio of mTEC
(shown in red) to cTEC (shown in blue) is decreased, but expression of MHCII is increased on individual
TEC, compared to WT. In the Gli3´/´ embryonic thymus—which has increased levels of Hh pathway
activation—the opposite phenotype is seen. TEC numbers are increased, but MHCII expression on
individual TEC is reduced compared to WT.
The influence of Shh on foetal TEC development was confirmed when WT FTOC were treated
with recombinant Hhip, a Hh-binding protein that neutralizes endogenous Hh proteins in the cultures.
Hhip-treatment led to an overall decrease in TEC cell numbers and a significant decrease in the
proportion of mature mTECs. The proportion of mTECs that expressed Aire protein was also reduced,
but there was an increase in cell surface MHC-II on the mTEC population [27].
The opposite was observed in Gli3´/´ foetal thymus (Figure 5). There was an increase in
overall TEC numbers but a decrease in cell surface expression of MHC-II in both cTEC and mTEC
populations (Figures 4B and 5) [29]. This is consistent with Gli3 acting as a suppressor of Shh in the
foetal thymus [27].
5. Conclusions and Future Directions
Hedgehog signalling influences multiple stages of T cell development, and also regulates foetal
TEC differentiation (Figures 3 and 5). Very few pathways or secreted signalling molecules have been
identified that regulate foetal TEC development or cTEC/mTEC lineage choice, so it will also be
important to identify the mechanisms of Shh’s regulation of TEC differentiation in the embryonic
thymus. It will be interesting to identify Hh target genes in different subsets of TEC, and test the
impact of mutation of these genes on TEC development and function, and on the ability of TEC to
support T cell development.
Hh signalling influences three key check-points in embryonic αβT cell development: the transition
from DN1 to DN2 cell; pre-TCR-induced differentiation to DP cell; and the transition from DP to
mature SP cell. The different mechanisms that account for these different developmental-stage specific
outcomes of Hh pathway activation in developing T cells are as yet unknown, and Hh target genes
have not been identified in thymocyte subsets.
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In the future, it will also be important to investigate the interactions between Hh signalling and
other pathways that interact with Hh signalling in other tissues, and also regulate foetal thymocyte
development—such as BMP2/4 signalling [48–50]. BMP2/4 signalling is also involved in early thymus
organogenesis and is required for early TEC development, so it will also be interesting to assess
interactions between BMP and Shh signalling in TEC development [51,52].
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